Literature DB >> 25648527

Mitochondrial Ca2+-dependent NLRP3 activation exacerbates the Pseudomonas aeruginosa-driven inflammatory response in cystic fibrosis.

Alessandro Rimessi1, Valentino Bezzerri2, Simone Patergnani1, Saverio Marchi1, Giulio Cabrini2, Paolo Pinton1.   

Abstract

The common pathological manifestation of cystic fibrosis (CF) is associated with an excessive lung inflammatory response characterized by interleukin-1β accumulation. CF airway epithelial cells show an exacerbated pro-inflammatory response to Pseudomonas aeruginosa; however, it is unclear whether this heightened inflammatory response is intrinsic to cells lacking CF transmembrane conductance regulator (CFTR). Here we demonstrate that the degree and quality of the inflammatory response in CF are supported by P. aeruginosa-dependent mitochondrial perturbation, in which flagellin is the inducer and mitochondrial Ca(2+) uniporter (MCU) is a signal-integrating organelle member for NLRP3 activation and IL-1β and IL-18 processing. Our work elucidates the regulation of the NLRP3 inflammasome by mitochondrial Ca(2+) in the P. aeruginosa-dependent inflammatory response and deepens our understanding of the significance of mitochondria in the Ca(2+)-dependent control of inflammation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25648527     DOI: 10.1038/ncomms7201

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  56 in total

Review 1.  The molecular era of the mitochondrial calcium uniporter.

Authors:  Kimberli J Kamer; Vamsi K Mootha
Journal:  Nat Rev Mol Cell Biol       Date:  2015-08-19       Impact factor: 94.444

Review 2.  The NLRP6 inflammasome in health and disease.

Authors:  Laxman Ghimire; Sagar Paudel; Liliang Jin; Samithamby Jeyaseelan
Journal:  Mucosal Immunol       Date:  2020-01-27       Impact factor: 7.313

Review 3.  Inflammation: A Double-Edged Sword in the Response to Pseudomonas aeruginosa Infection.

Authors:  Christina K Lin; Barbara I Kazmierczak
Journal:  J Innate Immun       Date:  2017-02-22       Impact factor: 7.349

Review 4.  Mitochondria in lung disease.

Authors:  Suzanne M Cloonan; Augustine M K Choi
Journal:  J Clin Invest       Date:  2016-03-01       Impact factor: 14.808

Review 5.  Mitochondrial biology in airway pathogenesis and the role of NRF2.

Authors:  Hye-Youn Cho; Steven R Kleeberger
Journal:  Arch Pharm Res       Date:  2019-09-04       Impact factor: 4.946

6.  Whole-blood transcriptomic responses to lumacaftor/ivacaftor therapy in cystic fibrosis.

Authors:  Benjamin T Kopp; James Fitch; Lisa Jaramillo; Chandra L Shrestha; Frank Robledo-Avila; Shuzhong Zhang; Sabrina Palacios; Fred Woodley; Don Hayes; Santiago Partida-Sanchez; Octavio Ramilo; Peter White; Asuncion Mejias
Journal:  J Cyst Fibros       Date:  2019-08-29       Impact factor: 5.482

7.  Pseudomonas aeruginosa Triggers Macrophage Autophagy To Escape Intracellular Killing by Activation of the NLRP3 Inflammasome.

Authors:  Qiuchan Deng; Yi Wang; Yuanqing Zhang; Meiyu Li; Dandan Li; Xi Huang; Yongjian Wu; Jieying Pu; Minhao Wu
Journal:  Infect Immun       Date:  2015-10-14       Impact factor: 3.441

8.  Succinate links mitochondria to deadly bacteria in cystic fibrosis.

Authors:  Speranza Esposito; Valeria Rachela Villella; Federica Rossin; Antonella Tosco; Valeria Raia; Alessandro Luciani
Journal:  Ann Transl Med       Date:  2019-12

Review 9.  Mitochondrial Ca2+ signaling.

Authors:  Trayambak Pathak; Mohamed Trebak
Journal:  Pharmacol Ther       Date:  2018-07-20       Impact factor: 12.310

Review 10.  Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases.

Authors:  Carlotta Giorgi; Saverio Marchi; Ines C M Simoes; Ziyu Ren; Giampaolo Morciano; Mariasole Perrone; Paulina Patalas-Krawczyk; Sabine Borchard; Paulina Jędrak; Karolina Pierzynowska; Jędrzej Szymański; David Q Wang; Piero Portincasa; Grzegorz Węgrzyn; Hans Zischka; Pawel Dobrzyn; Massimo Bonora; Jerzy Duszynski; Alessandro Rimessi; Agnieszka Karkucinska-Wieckowska; Agnieszka Dobrzyn; Gyorgy Szabadkai; Barbara Zavan; Paulo J Oliveira; Vilma A Sardao; Paolo Pinton; Mariusz R Wieckowski
Journal:  Int Rev Cell Mol Biol       Date:  2018-06-22       Impact factor: 6.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.